Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 609-610, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Junglee, D.
Right arrow Articles by Dandona, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Junglee, D.
Right arrow Articles by Dandona, P.

Clinical Chemistry, Vol 32, 609-610, Copyright © 1986 by American Association for Clinical Chemistry

Salivary amylase and pancreatic enzymes in serum after total body irradiation

D Junglee, A Katrak, J Mohiuddin, H Blacklock, HG Prentice and P Dandona

Amylase increases in serum after total body irradiation (TBI). To investigate whether this increase is ascribable to pancreatic or salivary amylase, or both, we measured the post-irradiation activity concentration of the three major pancreatic enzymes (trypsin, amylase, and lipase) and of salivary-type amylase in serum from six leukemic patients given TBI before bone-marrow transplantation. Salivary amylase increased by as much as 50-fold after TBI, peaking on the first day after the irradiation. The increase was associated with the development of clinical parotitis. Pancreatic trypsin, total amylase, and lipase increased inconsistently and to a much smaller degree. There were no associated clinical features of pancreatitis. Our data show that, at the dose of radiation given to our patients, there is no danger of pancreatitis as a complication, but parotitis is a consistent development after TBI.


The following articles in journals at HighWire Press have cited this article:


Home page
 JNMHome page
P. W. Rosario, M. A. R. Borges, and S. Purisch
Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
J. Nucl. Med., November 1, 2008; 49(11): 1776 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
T Hirama, S Tanosaki, S Kandatsu, N Kuroiwa, T Kamada, H Tsuji, S Yamada, H Katoh, N Yamamoto, H Tsujii, et al.
Initial medical management of patients severely irradiated in the Tokai-mura criticality accident
Br. J. Radiol., April 1, 2003; 76(904): 246 - 253.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.